Fees and Cost Structure: The Four Cost Blocks of Chile Registration
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The statutory principle for Chilean projects is clear: the final paragraph of Article 111 of the Sanitary Code provides that certification fees are borne by the natural or legal person filing the application. Specific amounts are charged according to the current ISP fee schedule (arancel), which varies with the product category and the type of filing (first registration, change, or renewal), and the schedule is adjusted by resolution. There is no single fixed fee for a medical device registration; the amount depends on what is filed, for which class, under which version of the schedule.
The GRZAN judgment: counting only the official fees will always understate the true cost. The real cost concentrates in four blocks: technical documentation engineering and Spanish localization, the lead times for obtaining the CFS and Apostilles, the compliance costs of the license holder, warehouse and import stages, and the opportunity cost of the review queue. Budgets that list only the arancel line look lean in the approval meeting and then bleed money in execution, because the expensive blocks are precisely the ones the official fee schedule does not mention. A credible budget names all four blocks and quantifies each one.
2. Legal basis
The following sources govern fees and the payment path:
- Sanitary Code of Chile (Código Sanitario) | DFL N° 725, de 1967 | final paragraph of Article 111 | certification fees are borne by the natural or legal person filing the application.
- Same instrument | Articles 111(a) and 111(b) | control and certification procedures, and the cases where the ISP performs the verification itself.
- Regulation on the control of pharmaceutical products and medical devices | Decreto Supremo N° 825, de 1998 | August 21, 1999 | Article 21: documentation requirements by category (which determine the documentation workload).
- ISP | current fee schedule (arancel) | charged per procedure and category, adjusted by resolution; specific amounts follow the current rates published by the ISP at the time of filing (practical estimate).
- ISP procedure | prestación 9100003 (v3, September 25, 2025) | payment is made through the TGR (Tesorería General de la República) or the ISP cashier.
3. Expert insights
Insight 1: official fees are usually a small share of total cost, but they are the easiest number to find.
Third-party figures circulate with obvious discrepancies: quotes for device categories and IVD categories do not match across sources. The inconsistency itself demonstrates that the rates adjust with each resolution. GRZAN’s practice is not to quote specific amounts, but to note that the applicable amount follows the current rates published by the ISP at the time of filing, and to verify the rate immediately before submission. This protects the budget from being anchored to an outdated number and protects the project team from defending a figure that the authority has since superseded. Anchoring the budget to a stale figure also invites disputes with finance when the real invoice arrives higher.
Insight 2: technical documentation engineering is the largest block, and it rises steeply by category.
Article 21 of Decreto Supremo N° 825, de 1998 sets requirements that escalate across four classes. Class I requires six basic documentation items, whereas Class IV requires scientific literature, efficacy and safety studies, studies in representative patient populations, studies of inherent risks, and biological studies: the workload is not on the same order of magnitude. For Class III and Class IV products, the documentation engineering cycle is usually measured in months (practical estimate). Budgeting Class IV work with Class I effort assumptions is the single most common source of schedule collapse in Chilean market-entry projects. The engineering effort includes Spanish localization, which is a specialized task and not a simple translation of the English file.
Insight 3: the certification lead time is the hidden critical path.
The CFS and the Apostille involve notarization, foreign affairs and consular steps, and the cycle is commonly measured in weeks (practical estimate). Running these steps serially after the documentation work directly erodes the early-filing window. The fix is sequencing, not effort: start the CFS and Apostille track in parallel with the documentation engineering, so that both arrive at the submission point together. A project that treats authentication as a paperwork errand typically discovers, one week before the planned submission, that the document chain is still in a ministry queue abroad. Authentication offices in different countries have different queues, so the lead time must be measured locally, not assumed globally.
Insight 4: the opportunity cost of queueing is the most expensive item.
The ISP will self-verify 39 new categories, and a queue during 2027–2028 is inevitable. Filing one quarter late can mean receiving the certificate only after the mandatory deadline, forcing a channel interruption. That cost, measured in lost sales and broken distributor relationships, dwarfs any fee line in the budget. It is also the cost that a spreadsheet built around official fees never captures, which is why the four-block budget structure matters: it forces the queue to be priced into the decision. In a queue, time is the currency, and every week of delay has a price that the budget should make explicit.
4. Practical recommendations
- Structure the budget in four blocks: technical documentation engineering and localization; certification and authentication; license holding, warehousing and import; opportunity cost.
- State official fees as subject to the current ISP rates at the time of filing, without quoting a fixed amount, and verify before submission.
- Start the CFS and Apostille track in parallel with the documentation work, never serially behind it.
- Reserve monthly-scale documentation cycles for Class III and Class IV projects; do not schedule Class IV work at a Class I pace.
- Translate the value of filing one quarter earlier into a cost saving, and write it into the project justification.
5. Verification checklist
- □ The budget lists the four blocks, not only the official fees
- □ The fee basis is stated as subject to the current ISP rates
- □ The CFS and Apostille track started in parallel with the documentation work
- □ Class III/IV projects reserve monthly-scale documentation cycles
- □ The paying entity matches the applicant (TGR or the ISP cashier)
Regulatory information verified as of October 29, 2026.
GRZAN supports medical device manufacturers entering the Chilean market with end-to-end services covering the local license holder and importer setup, full four-block fee and budget modeling under the current ISP arancel, and hands-on submission planning. Whether you need a cost model for your product class, a payment-path walkthrough via TGR, or filing support through GICONA, our regulatory team is ready to help. Contact us at info@grzanglobal.com.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us